Company news
Sol-Gel Technologies Ltd. news in 2024
Sol-Gel Technologies Ltd.'s news releases, calls and decks from 2024, newest first.
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
November 19, 2024
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
November 14, 2024
Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 15, 2024
Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa
July 24, 2024
Sol-Gel Technologies Announces Management Realignment
July 14, 2024
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
May 27, 2024
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 19, 2024
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
May 15, 2024
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
March 31, 2024
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
March 12, 2024